ABBV,US STOCKS-Tekmira Pharma, AbbVie among premarket actives NEW YORK, Sept 23 U.S.-listed shares of Tekmira Pharmaceuticals were climbing on Tuesday, up 8.9 percent at $25.70 as one of the most actively trades Nasdaq stocks as its Ebola drug will be one of several to be tested in West Africa in a bid to win fast-track trials. 
AGN,US STOCKS-Tekmira Pharma, AbbVie among premarket activesUS STOCKS-Wall St to open down after U.S. strikes in Syria, inversion movesAckman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.    Ackman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   NEW YORK, Sept 23 U.S. stocks were set for a lower open on Tuesday, putting the S&P; on pace for a third straight fall, as conflict in the Middle East intensified and after the U.S. Treasury moved to curb "tax inversion" deals.Ackman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.     US STOCKS-Wall St to open down after U.S. strikes in Syria, inversion movesAckman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.    Ackman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   NEW YORK, Sept 23 U.S. stocks were set for a lower open on Tuesday, putting the S&P; on pace for a third straight fall, as conflict in the Middle East intensified and after the U.S. Treasury moved to curb "tax inversion" deals.Ackman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.    NEW YORK, Sept 23 U.S.-listed shares of Tekmira Pharmaceuticals were climbing on Tuesday, up 8.9 percent at $25.70 as one of the most actively trades Nasdaq stocks as its Ebola drug will be one of several to be tested in West Africa in a bid to win fast-track trials.US STOCKS-Wall St to open down after U.S. strikes in Syria, inversion movesAckman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.    Ackman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   NEW YORK, Sept 23 U.S. stocks were set for a lower open on Tuesday, putting the S&P; on pace for a third straight fall, as conflict in the Middle East intensified and after the U.S. Treasury moved to curb "tax inversion" deals.Ackman again threatens to sue Allergan over potential Salix dealUPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.   UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  Sept 23 Billionaire William Ackman-backed Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if it went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.UPDATE 1-Allergan ordered to show 'business strategy' docs: FrankelUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.  UPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. NEW YORK    Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would expUPDATE 1-Ackman threatens to sue Allergan again over potential Salix deal Sept 23 Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.     
GOOGL,Google to build 600 mln euro data centre in the NetherlandsGoogle to build 600 million euro data center in the NetherlandsEU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire  EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire AMSTERDAM Google will build a 600 million euro ($773.58 million) data center in the northern Netherlands, the company said on Tuesday.EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire   Google to build 600 million euro data center in the NetherlandsEU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire  EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire AMSTERDAM Google will build a 600 million euro ($773.58 million) data center in the northern Netherlands, the company said on Tuesday.EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire  AMSTERDAM, Sept 23 Google will build a 600 million euro (773.58 million US dollar) data centre in the northern Netherlands, the company said on Tuesday.Google to build 600 million euro data center in the NetherlandsEU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire  EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire AMSTERDAM Google will build a 600 million euro ($773.58 million) data center in the northern Netherlands, the company said on Tuesday.EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire   
GOOG,Google to build 600 mln euro data centre in the NetherlandsGoogle to build 600 million euro data center in the NetherlandsEU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire  EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire AMSTERDAM Google will build a 600 million euro ($773.58 million) data center in the northern Netherlands, the company said on Tuesday.EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire   Google to build 600 million euro data center in the NetherlandsEU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire  EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire AMSTERDAM Google will build a 600 million euro ($773.58 million) data center in the northern Netherlands, the company said on Tuesday.EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire  AMSTERDAM, Sept 23 Google will build a 600 million euro (773.58 million US dollar) data centre in the northern Netherlands, the company said on Tuesday.Google to build 600 million euro data center in the NetherlandsEU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire  EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire AMSTERDAM Google will build a 600 million euro ($773.58 million) data center in the northern Netherlands, the company said on Tuesday.EU's Almunia says may probe Google's non-search services * Google's non-search services such as Google+, YouTube under fire   
AAPL,China regulator says iPhone 6 in final review stages -Tencent BEIJING, Sept 23 Apple Inc's iPhone 6 is in the final stages of review for approval, with results due shortly, a top Chinese government regulator said in an interview published on Tuesday by Tencent. 
BAC,Walgreen explores sale of $1.5 bln infusion business -sources NEW YORK, Sept 23 U.S. drugstore chain operator Walgreen Co is exploring the sale of a majority stake in its infusion services business, in a deal that could value that division at around $1.5 billion, according to four people familiar with the matter. 
BBBY,Bed Bath & Beyond posts higher sales, shares riseUPDATE 1-Bed Bath & Beyond's revenue beats estimates, shares rise Sept 23 Home furnishings retailer Bed Bath & Beyond Inc reported better-than-expected quarterly revenue as increased discounting and promotions helped attract more shoppers to its stores.  UPDATE 1-Bed Bath & Beyond's revenue beats estimates, shares rise Sept 23 Home furnishings retailer Bed Bath & Beyond Inc reported better-than-expected quarterly revenue as increased discounting and promotions helped attract more shoppers to its stores. Sept 23 Home furnishings retailer Bed Bath & Beyond Inc reported a 4.3 percent jump in quarterly sales as increased discounting and promotions helped attract more shoppers to its stores.UPDATE 1-Bed Bath & Beyond's revenue beats estimates, shares rise Sept 23 Home furnishings retailer Bed Bath & Beyond Inc reported better-than-expected quarterly revenue as increased discounting and promotions helped attract more shoppers to its stores.  
BA,Boeing, Liquid Robotics to cooperate on maritime surveillanceCORRECTED-Turkish Airlines says studying more jet purchasesUPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference.  UPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference. (In fifth paragraph, corrects 2014 traffic forecast, adds 2013 comparison)UPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference.   CORRECTED-Turkish Airlines says studying more jet purchasesUPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference.  UPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference. (In fifth paragraph, corrects 2014 traffic forecast, adds 2013 comparison)UPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference.  WASHINGTON, Sept 23 Boeing Co, the No. 2 supplier to the U.S. Defense Department, and Liquid Robotics, a top supplier of autonomous ocean vehicles, on Tuesday said they had signed a multiyear agreement to collaborate on products for maritime surveillance.CORRECTED-Turkish Airlines says studying more jet purchasesUPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference.  UPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference. (In fifth paragraph, corrects 2014 traffic forecast, adds 2013 comparison)UPDATE 1-Turkish Airlines says studying more jet purchases ISTANBUL, Sept 23 Turkish Airlines is considering options to increase its fleet of Airbus and Boeing passenger aircraft, though it has yet to decide on size or quantity, airline executives told a finance industry conference.   
KMX,CarMax revenue rises 11 pct as used car sales increaseUPDATE 1-CarMax hurt by slower growth in unit sales at used-car storesUPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay.  UPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay. Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used car lots slowed to a near halt.UPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay.   UPDATE 1-CarMax hurt by slower growth in unit sales at used-car storesUPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay.  UPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay. Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used car lots slowed to a near halt.UPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay.  Sept 23 CarMax Inc, the largest U.S. used car retailer, reported a 11 percent rise in quarterly revenue as easier availability of credit boosted car sales.UPDATE 1-CarMax hurt by slower growth in unit sales at used-car storesUPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay.  UPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay. Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used car lots slowed to a near halt.UPDATE 2-Tighter subprime lending hurts used-car retailer CarMax Sept 23 CarMax Inc, the largest U.S. used-car retailer, reported a lower-than-expected quarterly profit as growth in comparable unit sales at its used-car lots slowed to a near halt, hurt by tighter lending norms that kept subprime customers at bay.   
CCL,Carnival Corp's revenue rises on higher demand for Asia cruisesUPDATE 2-Carnival shifts COO to Shanghai as Asia cruise business booms * Shares touch highest in more than three years   (Adds details from conference call, updates shares)  UPDATE 2-Carnival shifts COO to Shanghai as Asia cruise business booms * Shares touch highest in more than three years   (Adds details from conference call, updates shares) Sept 23 Carnival Corp, the world's largest cruise operator, reported a 4.7 percent rise in quarterly revenue, helped by higher demand for its Asia cruises.UPDATE 2-Carnival shifts COO to Shanghai as Asia cruise business booms * Shares touch highest in more than three years   (Adds details from conference call, updates shares)  
CELG,Celgene's psoriasis drug gets approval for new indicationUPDATE 1-Celgene's psoriasis drug gets approval for new indication Sept 23 Celgene Corp said the U.S. Food and Drugs Administration has approved the expanded use of its drug Otezla for treating patients with moderate to severe plaque psoriasis.  UPDATE 1-Celgene's psoriasis drug gets approval for new indication Sept 23 Celgene Corp said the U.S. Food and Drugs Administration has approved the expanded use of its drug Otezla for treating patients with moderate to severe plaque psoriasis. Sept 23 Celgene Corp said U.S. health regulators have approved the expanded use of its drug Otezla for treating patients with moderate to severe plaque psoriasis.UPDATE 1-Celgene's psoriasis drug gets approval for new indication Sept 23 Celgene Corp said the U.S. Food and Drugs Administration has approved the expanded use of its drug Otezla for treating patients with moderate to severe plaque psoriasis.  
CF,Yara in talks with CF Industries on merger of equalsUPDATE 4-Norway's Yara, CF in talks to create $27.5 bln global fertiliser producer * Potential merged company would rival Potash Corp in market cap  UPDATE 4-Norway's Yara, CF in talks to create $27.5 bln global fertiliser producer * Potential merged company would rival Potash Corp in market cap OSLO, Sept 23 Fertiliser producer Yara International is in talks with CF Industries  about a possible merger of equals, the Norwegian firm said on Tuesday.UPDATE 4-Norway's Yara, CF in talks to create $27.5 bln global fertiliser producer * Potential merged company would rival Potash Corp in market cap  
DE,Deere to explore strategic options for crop insurance businessUPDATE 1-Deere to explore strategic options for crop insurance unit Sept 23 Deere & Co, the world's largest farm equipment maker, said it was exploring strategic options for its low-margin crop insurance business and had hired Citigroup as its adviser.  UPDATE 1-Deere to explore strategic options for crop insurance unit Sept 23 Deere & Co, the world's largest farm equipment maker, said it was exploring strategic options for its low-margin crop insurance business and had hired Citigroup as its adviser. Sept 23 Farm equipment maker Deere & Co  said it was exploring strategic options for its crop insurance business and had hired Citigroup as its adviser.UPDATE 1-Deere to explore strategic options for crop insurance unit Sept 23 Deere & Co, the world's largest farm equipment maker, said it was exploring strategic options for its low-margin crop insurance business and had hired Citigroup as its adviser.  
XOM,UPDATE 2-Indonesia's Widodo unveils energy action plan, to halt Petral oil trading * Widodo to also impose major changes at state-owned Pertamina 
FB,FEATURE-Movies bust out of screen with panoramic, virtual technology LOS ANGELES, Sept 23 A Tyrannosaurus rex lumbers forward, belts out a deafening roar, then stomps overhead, and a viewer watching inside a virtual reality headset turns around to see the beast walking away. 
GM,GM's Cadillac brand to open headquarters in New YorkGM's Cadillac brand to open headquarters in New YorkGeneral Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers.  General Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers. DETROIT General Motors Co  said on Tuesday its Cadillac brand will open a headquarters in New York next year in a move to remake the luxury marque's image and broaden its appeal outside North America.General Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers.   GM's Cadillac brand to open headquarters in New YorkGeneral Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers.  General Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers. DETROIT General Motors Co  said on Tuesday its Cadillac brand will open a headquarters in New York next year in a move to remake the luxury marque's image and broaden its appeal outside North America.General Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers.  DETROIT, Sept 23 General Motors Co said on Tuesday its Cadillac brand will open a headquarters in New York next year in a move to remake the luxury marque's image and broaden its appeal outside North America.GM's Cadillac brand to open headquarters in New YorkGeneral Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers.  General Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers. DETROIT General Motors Co  said on Tuesday its Cadillac brand will open a headquarters in New York next year in a move to remake the luxury marque's image and broaden its appeal outside North America.General Motors appoints its first cybersecurity chief BOSTON/DETROIT, Sept 23 General Motors Co  on Tuesday named an engineer to serve as its first cybersecurity chief as the No. 1 U.S. automaker and its rivals come under increasing pressure to better secure their vehicles against hackers.   
HCA,U.S. hospital chain HCA must face class action over 2011 IPO Sept 23 HCA Holdings Inc, one of the largest U.S. hospital chains, must face a shareholder class-action lawsuit accusing it of concealing revenue declines and its routine performance of unnecessary cardiac procedures prior to its $4.35 billion initial public offering in March 2011. 
HD,Home Depot data breach triggers fraudulent transactions: WSJ Sept 23 Data breach at home improvement retailer Home Depot Inc has led to fraudulent transactions across the United States, draining cash from customer bank accounts, the Wall Street Journal said. 
MDT,UPDATE 3-U.S. Treasury moves against tax-avoidance 'inversion' deals WASHINGTON, Sept 22 Moving against tax avoidance by corporations, the Obama administration took several actions on Monday to curb  "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad. 
MSFT,Facebook to introduce new advertising platform -WSJMicrosoft Xbox One set to launch in China on Sept 29UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year.  UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year. BEIJING, Sept 23 Microsoft Corp's Xbox One videogame console will launch in China on Sept. 29, the U.S. software giant said on Tuesday, following its announcement last week of a delay from the original launch date of Sept. 23.UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year.   Microsoft Xbox One set to launch in China on Sept 29UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year.  UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year. BEIJING, Sept 23 Microsoft Corp's Xbox One videogame console will launch in China on Sept. 29, the U.S. software giant said on Tuesday, following its announcement last week of a delay from the original launch date of Sept. 23.UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year.  Sept 22 Facebook Inc is set to unveil a new advertising platform to improve effectiveness of online ads, the Wall Street Journal reported on Monday citing people with knowledge of the matter.Microsoft Xbox One set to launch in China on Sept 29UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year.  UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year. BEIJING, Sept 23 Microsoft Corp's Xbox One videogame console will launch in China on Sept. 29, the U.S. software giant said on Tuesday, following its announcement last week of a delay from the original launch date of Sept. 23.UPDATE 1-Microsoft Xbox One set to launch in China on Sept 29 BEIJING, Sept 23 Microsoft Corp has set Sept. 29 as the new launch date for its Xbox One game console in China, the U.S. software giant said on Tuesday, in the first launch since a 14-year ban on sales of foreign games consoles was lifted this year.   
NEM,Newmont raises full-year copper production forecast Sept 23 Newmont Mining Corp raised its full-year copper production forecast to reflect the resumption of shipments from Indonesia. 
NOC,U.S. Navy says better reliability may trim order for Northrop drones NAVAL AIR STATION PATUXENT RIVER, Maryland, Sept 23 A senior U.S. Navy official on Tuesday said improved reliability may allow the Navy to buy fewer than the 68 Northrop Grumman Corp high-altitude, unmanned Triton spy planes now planned. 
ORCL,Oracle's Ellison got $67.3 mln as CEO in 2014UPDATE 2-Oracle's Ellison took smaller pay package in fiscal 2014 Sept 23 Oracle Corp's Larry Ellison, who is stepping aside as chief executive officer, took less money home in fiscal 2014 that the year before following criticism of his compensation and concerns about the software company's struggles against smaller rivals.  UPDATE 2-Oracle's Ellison took smaller pay package in fiscal 2014 Sept 23 Oracle Corp's Larry Ellison, who is stepping aside as chief executive officer, took less money home in fiscal 2014 that the year before following criticism of his compensation and concerns about the software company's struggles against smaller rivals. Sept 23 Oracle Corp's Larry Ellison's salary as chief executive dropped 15.5 percent to $67.3 million in 2014, according to a company filing on Tuesday.UPDATE 2-Oracle's Ellison took smaller pay package in fiscal 2014 Sept 23 Oracle Corp's Larry Ellison, who is stepping aside as chief executive officer, took less money home in fiscal 2014 that the year before following criticism of his compensation and concerns about the software company's struggles against smaller rivals.  
PFE,REPEAT-UPDATE 2-AstraZeneca, Shire dive as U.S. tax move punctures deal hopesWRAPUP 1-Shares of 'inversion' candidates slide on U.S. tax ruleWRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)    WRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   * Action may deter Pfizer from returning to bid for AstraZenecaWRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)     WRAPUP 1-Shares of 'inversion' candidates slide on U.S. tax ruleWRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)    WRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   * Action may deter Pfizer from returning to bid for AstraZenecaWRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)    * Seen as possible threat to Shire's agreed sale to AbbVieWRAPUP 1-Shares of 'inversion' candidates slide on U.S. tax ruleWRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)    WRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   * Action may deter Pfizer from returning to bid for AstraZenecaWRAPUP 2-New U.S. tax rules chill 'inversion' deal-making; shares divePfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)   Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  * Action may deter Pfizer from returning to bid for AstraZeneca   (Recasts with Medtronic comments, update stock moves)Pfizer approaches Actavis to gauge interest in deal: BloombergDeals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)  Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica) Pfizer Inc  has approached Dublin-based generic drugmaker Actavis Plc  to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter.Deals of the day- Mergers and acquisitions (Adds Deere, Pfizer, Pershing Square Capital Management, Spirit Pub, Alstom, Procter & Gamble, Total, ZF Friedrichshafen, WSE, Jost Group, Grupo Oi, Eurobank Ergasias, UniCredit and Telefonica)     
PG,MOVES-Advent names P&G; exec Werner Geissler as operating partnerSpectrum Brands to buy P&G;'s remaining pet food businessUPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.   UPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  Sept 23 Consumer products company Spectrum Brands Holdings Inc said it would buy Procter & Gamble Co's European pet food business, which includes the Iams and Eukanuba dog and cat food brands.UPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.    Spectrum Brands to buy P&G;'s remaining pet food businessUPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.   UPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  Sept 23 Consumer products company Spectrum Brands Holdings Inc said it would buy Procter & Gamble Co's European pet food business, which includes the Iams and Eukanuba dog and cat food brands.UPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.   Sept 23 Private equity firm Advent International Corp said it had appointed Procter & Gamble Co executive Werner Geissler as an operating partner, effective from Jan. 1.Spectrum Brands to buy P&G;'s remaining pet food businessUPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.   UPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  Sept 23 Consumer products company Spectrum Brands Holdings Inc said it would buy Procter & Gamble Co's European pet food business, which includes the Iams and Eukanuba dog and cat food brands.UPDATE 1-P&G; to exit pet food with sale of European businessP&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.  P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers. Sept 23 Procter & Gamble Co said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.P&G; to exit pet food with sale of European business Procter & Gamble Co  said it would sell the last of its pet food business to consumer products company Spectrum Brands Holdings Inc  as it focuses on more profitable lines such as Tide detergent, Gillette razors and Pampers diapers.    
SBUX,Starbucks to buy out joint venture partner in JapanUPDATE 2-Starbucks buying full control of Japan unit for $914 mln Sept 23 Starbucks Corp on Tuesday said it plans to buy the remaining 60.5 percent share of Starbucks Coffee Japan Ltd that it does not already own in a two-step deal valued at about $913.5 million.  UPDATE 2-Starbucks buying full control of Japan unit for $914 mln Sept 23 Starbucks Corp on Tuesday said it plans to buy the remaining 60.5 percent share of Starbucks Coffee Japan Ltd that it does not already own in a two-step deal valued at about $913.5 million. Sept 23 Starbucks Corp <SBUX.O > on Tuesday said it plans to buy the remaining 60.5 percent share of Starbucks Coffee Japan Ltd that it does not already own, in a two-step deal valued at about $913.5 million.UPDATE 2-Starbucks buying full control of Japan unit for $914 mln Sept 23 Starbucks Corp on Tuesday said it plans to buy the remaining 60.5 percent share of Starbucks Coffee Japan Ltd that it does not already own in a two-step deal valued at about $913.5 million.  
SYY,U.S. FTC mulling antitrust lawsuit against Sysco, US Foods deal -WSJ Sept 22 The U.S. Federal Trade Commission is considering a possible antitrust lawsuit against Sysco Corp's  $3.5 billion deal to buy debt-ridden US Foods from private equity, the Wall Street Journal reported on Monday citing people with knowledge of the matter. 
DIS,FEATURE-Movies bust out of screen with panoramic, virtual technology LOS ANGELES, Sept 23 A Tyrannosaurus rex lumbers forward, belts out a deafening roar, then stomps overhead, and a viewer watching inside a virtual reality headset turns around to see the beast walking away. 
TWX,Colin Farrell, Vince Vaughn to star in 'True Detective' second seasonUPDATE 1-Colin Farrell, Vince Vaughn to star in 'True Detective' (Adds details on show and background on actors throughout)  UPDATE 1-Colin Farrell, Vince Vaughn to star in 'True Detective' (Adds details on show and background on actors throughout) LOS ANGELES, Sept 23 Actors Colin Farrell and Vince Vaughn will take leading roles in the second season of HBO's crime thriller "True Detective," Time Warner Inc's  cable network said on Tuesday.UPDATE 1-Colin Farrell, Vince Vaughn to star in 'True Detective' (Adds details on show and background on actors throughout)  
UAL,United settles U.S. discrimination claimsUnited settles U.S. discrimination claims WASHINGTON United Continental Holdings Inc agreed to pay $215,000 to resolve claims that Continental discriminated against its lawful permanent resident employees by demanding they fill out extra forms, the U.S. Justice Department said on Tuesday.  United settles U.S. discrimination claims WASHINGTON United Continental Holdings Inc agreed to pay $215,000 to resolve claims that Continental discriminated against its lawful permanent resident employees by demanding they fill out extra forms, the U.S. Justice Department said on Tuesday. WASHINGTON, Sept 23 United Continental Holdings Inc agreed to pay $215,000 to resolve claims that Continental discriminated against its lawful permanent resident employees by demanding they fill out extra forms, the U.S. Justice Department said on Tuesday.United settles U.S. discrimination claims WASHINGTON United Continental Holdings Inc agreed to pay $215,000 to resolve claims that Continental discriminated against its lawful permanent resident employees by demanding they fill out extra forms, the U.S. Justice Department said on Tuesday.  
UPS,REFILE-Israel turns self-defence into industry boom for cyber techsUPDATE 3-Three killed, including shooter, at UPS facility in Alabama BIRMINGHAM, Ala., Sept 23 A man in United Parcel Service uniform fatally shot two workers on Tuesday and then killed himself at a UPS facility in Birmingham, Alabama, police said.  UPDATE 3-Three killed, including shooter, at UPS facility in Alabama BIRMINGHAM, Ala., Sept 23 A man in United Parcel Service uniform fatally shot two workers on Tuesday and then killed himself at a UPS facility in Birmingham, Alabama, police said. * Israel accounts for 13 pct of new global R&D; in cyber securityUPDATE 3-Three killed, including shooter, at UPS facility in Alabama BIRMINGHAM, Ala., Sept 23 A man in United Parcel Service uniform fatally shot two workers on Tuesday and then killed himself at a UPS facility in Birmingham, Alabama, police said.  
VZ,Verizon hires TAP Advisors to plan sale of assets Sept 23 Verizon Communications Inc has hired investment bank TAP Advisors LLC to plan a sale of its network's assets including its cell towers, according to a source familiar with the matter. 
WMT,"Frozen" princess promises hot Christmas for struggling toymaker Sept 23 Snow Glow Elsa has a big job ahead of her - even for a princess with magical powers. 
